AREV Life Sciences Global Corp. (AREVF)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | 49.11 Thousand | 254.99 Thousand | 190.57 Thousand | 194.68 Thousand | - | - |
| Cost of Revenue | 125.59 Thousand | 146.45 Thousand | 148.65 Thousand | 65.56 Thousand | 52.46 Thousand | 51.58 Thousand |
| Gross Profit | -76.47 Thousand | 108.54 Thousand | 41.92 Thousand | 129.12 Thousand | -52.46 Thousand | -51.58 Thousand |
| Operating Expenses | 49.11 Thousand | 1.92 Million | 843.71 Thousand | 3.22 Million | 1.69 Million | 824.37 Thousand |
| Selling, General and Administrative Expenses | 1.19 Million | 1.62 Million | 567.05 Thousand | 2 Million | 1.63 Million | 772.79 Thousand |
| Research and Development Expenses | 84.01 Thousand | 148.32 Thousand | 128 Thousand | 1.14 Million | 195 Thousand | - |
| Other Expenses | - | -4630.00 | - | -97.38 Thousand | -41.88 Thousand | - |
| Cost and Expenses | 1.44 Million | 1.92 Million | 843.71 Thousand | 3.22 Million | 1.69 Million | 824.37 Thousand |
| Operating Income | -1.38 Million | -1.66 Million | -653.14 Thousand | -3.02 Million | -1.69 Million | -849.03 Thousand |
| Interest Expense | 6089.00 | 46.22 Thousand | 58.81 Thousand | 73.22 Thousand | 40.16 Thousand | 36.62 Thousand |
| Income Tax Expense | - | 46.22 Thousand | 58.81 Thousand | 73.22 Thousand | 40.16 Thousand | 11.97 Thousand |
| Earnings before Tax | -1.44 Million | -990.31 Thousand | -1.04 Million | -3.19 Million | -8.42 Million | -1.01 Million |
| Net Income | -1.44 Million | -990.31 Thousand | -1.04 Million | -3.19 Million | -8.42 Million | -1.01 Million |
| Earnings Per Share Basic | -0.05 | -0.05 | -0.07 | -0.36 | -1.47 | -0.42 |
| Earnings Per Share Diluted | -0.05 | -0.05 | -0.07 | -0.36 | -1.47 | -0.42 |
| Weighted Average Shares Outstanding | 30.07 Million | 19.58 Million | 15.36 Million | 8.95 Million | 5.73 Million | 2.41 Million |
| Weighted Average Shares Outstanding (Diluted) | 30.07 Million | 19.58 Million | 15.36 Million | 8.95 Million | 5.73 Million | 2.41 Million |
| Gross Margin | -1.56 | 0.43 | 0.22 | 0.66 | - | - |
| EBIT Margin | -26.72 | -5.96 | -2.65 | -15.21 | - | - |
| Profit Margin | -29.40 | -3.88 | -5.50 | -16.40 | - | - |
| EBITDA | -1.31 Million | -797.63 Thousand | -504.48 Thousand | -3.05 Million | -1.63 Million | -797.45 Thousand |
| Earnings Before Tax Margin | -28.28 | -6.54 | -3.43 | -15.54 | - | - |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 7209.00 | 49.11 Thousand | 23.08 Thousand |
| Cost of Revenue | 13.83 Thousand | 13.83 Thousand | 13.83 Thousand | 28.82 Thousand | 125.59 Thousand | 32.48 Thousand |
| Gross Profit | -13.83 Thousand | -13.83 Thousand | -13.83 Thousand | -21.61 Thousand | -76.47 Thousand | -9392.00 |
| Operating Expenses | 27.98 Thousand | 119.53 Thousand | 166.03 Thousand | -95.9 Thousand | 1.44 Million | 242.89 Thousand |
| Selling, General and Administrative Expenses | -1861.00 | 73.99 Thousand | 145.62 Thousand | -144.74 Thousand | - | 205.17 Thousand |
| Research and Development Expenses | - | 27.21 Thousand | - | 6559.00 | - | 5240.00 |
| Other Expenses | 29.84 Thousand | - | - | -19.97 Thousand | -19.97 Thousand | - |
| Cost and Expenses | 27.98 Thousand | 119.53 Thousand | 166.03 Thousand | -95.9 Thousand | 1.44 Million | 242.89 Thousand |
| Operating Income | -27.98 Thousand | -119.53 Thousand | -166.03 Thousand | 103.11 Thousand | -1.39 Million | -219.8 Thousand |
| Interest Expense | 945.00 | 944.00 | 939.00 | 1156.00 | 6089.00 | 3543.00 |
| Income Tax Expense | 53.42 Thousand | 944.00 | 939.00 | 1157.00 | 6089.00 | 19.39 Thousand |
| Earnings before Tax | -28.92 Thousand | -120.82 Thousand | -169.37 Thousand | 79.58 Thousand | -1.44 Million | -224.8 Thousand |
| Net Income | -28.92 Thousand | -120.82 Thousand | -169.37 Thousand | 79.58 Thousand | -1.44 Million | -240.65 Thousand |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.01 | 0.00 | - | -0.01 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.01 | 0.00 | - | -0.01 |
| Weighted Average Shares Outstanding | 31.76 Million | 31.76 Million | 31.71 Million | 31.53 Million | 30.07 Million | 30.56 Million |
| Weighted Average Shares Outstanding (Diluted) | 31.76 Million | 31.76 Million | 31.71 Million | 31.53 Million | 30.07 Million | 30.56 Million |
| Gross Margin | - | - | - | -3.00 | -1.56 | -0.41 |
| EBIT Margin | - | - | - | 18.30 | - | -8.11 |
| Profit Margin | - | - | - | 11.04 | -29.40 | -10.42 |
| EBITDA | -14.14 Thousand | -105.69 Thousand | -152.19 Thousand | 131.94 Thousand | - | -187.32 Thousand |
| Earnings Before Tax Margin | - | - | - | 14.30 | -28.40 | -9.52 |
IMAHF
CKPDY
0IR9
BTSGY
PLLR
HINDCOPPER